{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:14:07Z","timestamp":1777418047948,"version":"3.51.4"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>After an ischaemic stroke, atrial fibrillation (AF) detection allows for improved secondary prevention strategies. This study aimed to compare AF detection and oral anticoagulant (OAC) initiation in patients with an insertable cardiac monitor (ICM) vs. external cardiac monitor (ECM) after ischaemic stroke.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Medicare Fee-for-Service (FFS) insurance claims and Abbott Labs device registration data were used to identify patients hospitalized with an ischaemic stroke in 2017\u20132019 who received an ICM or ECM within 3 months. Patients with continuous Medicare FFS insurance and prescription drug enrolment in the prior year were included. Patients with prior AF, atrial flutter, cardiac devices, or OAC were excluded. Insertable cardiac monitor and ECM patients were propensity score matched 1:4 on demographics, comorbidities, and stroke hospitalization characteristics. The outcomes of interest were AF detection and OAC initiation evaluated with Kaplan\u2013Meier and Cox proportional hazard regression analyses. A total of 5702 Medicare beneficiaries (ICM, n = 444; ECM, n = 5258) met inclusion criteria. The matched cohort consisted of 2210 Medicare beneficiaries (ICM, n = 442; ECM, n = 1768) with 53% female, mean age 75 years, and mean CHA\u2082DS\u2082-VASc score 4.6 (1.6). Insertable cardiac monitor use was associated with a higher probability of AF detection [(hazard ratio (HR) 2.88, 95% confidence interval (CI) (2.31, 3.59)] and OAC initiation [HR 2.91, CI (2.28, 3.72)] compared to patients monitored only with ECM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Patients with an ischaemic stroke monitored with an ICM were almost three times more likely to be diagnosed with AF and to be prescribed OAC compared to patients who received ECM only.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euad212","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T16:10:04Z","timestamp":1690301404000},"source":"Crossref","is-referenced-by-count":10,"title":["Insertable cardiac monitoring results in higher rates of atrial fibrillation diagnosis and oral anticoagulation prescription after ischaemic stroke"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"first","affiliation":[{"name":"Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia , Via del Pozzo, 71, Modena 41124 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2116-6993","authenticated-orcid":false,"given":"Angelo","family":"Auricchio","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiocentro Ticino , Lugano , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8049-7517","authenticated-orcid":false,"given":"Giovanni Luca","family":"Botto","sequence":"additional","affiliation":[{"name":"Department of Cardiology\u2014Electrophysiology, ASST Rhodense, Civile Hospital Rho and Salvini Hospital Garbagnate Milanese Hospital , Milan , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9203-6275","authenticated-orcid":false,"given":"Jennifer M","family":"Joseph","sequence":"additional","affiliation":[{"name":"Medical Devices, Abbott , Santa Clara, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J","family":"Roberts","sequence":"additional","affiliation":[{"name":"Medical Devices, Abbott , Sylmar, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6204-8745","authenticated-orcid":false,"given":"Andrea","family":"Grammatico","sequence":"additional","affiliation":[{"name":"Medical Devices, Abbott , Rome , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yelena","family":"Nabutovsky","sequence":"additional","affiliation":[{"name":"Medical Devices, Abbott , Santa Clara, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-2404","authenticated-orcid":false,"given":"Jonathan P","family":"Piccini","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University , Durham, NC , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"2023080419242176200_euad212-B1","first-page":"e99","article-title":"Searching for atrial fibrillation poststroke: a white paper of the AF-SCREEN international collaboration","volume":"141","author":"Schnabel","year":"2020","journal-title":"Circulation"},{"key":"2023080419242176200_euad212-B2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.amjmed.2014.11.026","article-title":"Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry","volume":"128","author":"Boriani","year":"2015","journal-title":"Am J Med"},{"key":"2023080419242176200_euad212-B3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(15)70027-X","article-title":"Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis","volume":"14","author":"Sposato","year":"2015","journal-title":"Lancet Neurol"},{"key":"2023080419242176200_euad212-B4","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.3390\/jcm10173979","article-title":"Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: a systematic review and meta-analysis of 81,462 patients","volume":"10","author":"Sgreccia","year":"2021","journal-title":"J Clin Med"},{"key":"2023080419242176200_euad212-B5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"key":"2023080419242176200_euad212-B6","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1093\/eurheartj\/ehab648","article-title":"Corrigendum to: 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2023080419242176200_euad212-B7","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.hrthm.2019.01.024","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"16","author":"January","year":"2019","journal-title":"Heart Rhythm"},{"key":"2023080419242176200_euad212-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2021.01.006","article-title":"Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology","volume":"86","author":"Boriani","year":"2021","journal-title":"Eur J Intern Med"},{"key":"2023080419242176200_euad212-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2022.04.023","article-title":"Comparing atrial fibrillation guidelines: focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations","volume":"101","author":"Imberti","year":"2022","journal-title":"Eur J Intern Med"},{"key":"2023080419242176200_euad212-B10","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/eurheartj\/ehac245","article-title":"Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke","volume":"43","author":"Lip","year":"2022","journal-title":"Eur Heart J"},{"key":"2023080419242176200_euad212-B11","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"2023080419242176200_euad212-B12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vph.2016.03.006","article-title":"Atrial fibrillation burden and atrial fibrillation type: clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation","volume":"83","author":"Boriani","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"2023080419242176200_euad212-B13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrcardio.2017.94","article-title":"Management of atrial high-rate episodes detected by cardiac implanted electronic devices","volume":"14","author":"Freedman","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2023080419242176200_euad212-B14","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"key":"2023080419242176200_euad212-B15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ahj.2009.04.002","article-title":"Linking inpatient clinical registry data to Medicare claims data using indirect identifiers","volume":"157","author":"Hammill","year":"2009","journal-title":"Am Heart J"},{"key":"2023080419242176200_euad212-B16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2017.06.039","article-title":"Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population","volume":"244","author":"Ziegler","year":"2017","journal-title":"Int J Cardiol"},{"key":"2023080419242176200_euad212-B17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejim.2021.06.022","article-title":"Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors","volume":"92","author":"Ungar","year":"2021","journal-title":"Eur J Intern Med"},{"key":"2023080419242176200_euad212-B18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.hroo.2022.02.006","article-title":"Longitudinal outcomes in cryptogenic stroke patients with and without long-term cardiac monitoring for atrial fibrillation","volume":"3","author":"Yaghi","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"2023080419242176200_euad212-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cvr\/cvab147","article-title":"Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes","volume":"117","author":"Boriani","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2023080419242176200_euad212-B20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/CIRCULATIONAHA.120.047633","article-title":"Research priorities in atrial fibrillation screening: A report from a national heart, lung, and blood institute virtual workshop","volume":"143","author":"Benjamin","year":"2021","journal-title":"Circulation"},{"key":"2023080419242176200_euad212-B21","doi-asserted-by":"crossref","first-page":"e003333","DOI":"10.1161\/CIRCEP.115.003333","article-title":"Uncovering atrial fibrillation beyond short-term monitoring in cryptogenic stroke patients: three-year results from the cryptogenic stroke and underlying atrial fibrillation trial","volume":"9","author":"Brachmann","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023080419242176200_euad212-B22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijcard.2019.07.039","article-title":"Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group","volume":"296","author":"Boriani","year":"2019","journal-title":"Int J Cardiol"},{"key":"2023080419242176200_euad212-B23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejim.2022.06.023","article-title":"Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-regression","volume":"103","author":"Proietti","year":"2022","journal-title":"Eur J Intern Med"},{"key":"2023080419242176200_euad212-B24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.0000000000002282","article-title":"Predictors for atrial fibrillation detection after cryptogenic stroke: results from CRYSTAL AF","volume":"86","author":"Thijs","year":"2016","journal-title":"Neurology"},{"key":"2023080419242176200_euad212-B25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am J Med"},{"key":"2023080419242176200_euad212-B26","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jacc.2009.04.091","article-title":"Quality of care for atrial fibrillation among patients hospitalized for heart failure","volume":"54","author":"Piccini","year":"2009","journal-title":"JACC"},{"key":"2023080419242176200_euad212-B27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/europace\/euab303","article-title":"Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis","volume":"24","author":"Grymonprez","year":"2022","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/europace\/eux301","article-title":"Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry","volume":"20","author":"Boriani","year":"2018","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/europace\/euab313","article-title":"Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the \u2018transition era\u2019 to non-vitamin K antagonist oral anticoagulants","volume":"24","author":"Ritchie","year":"2022","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40256-021-00502-9","article-title":"Direct oral anticoagulants and warfarin for atrial fibrillation treatment: rural and urban trends in Medicare beneficiaries","volume":"22","author":"Norby","year":"2022","journal-title":"Am J Cardiovasc Drugs"},{"key":"2023080419242176200_euad212-B31","doi-asserted-by":"crossref","first-page":"e007943","DOI":"10.1161\/JAHA.117.007943","article-title":"Provider specialty, anticoagulation prescription patterns, and stroke risk in atrial fibrillation","volume":"7","author":"O\u2019Neal","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2023080419242176200_euad212-B32","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/STROKEAHA.119.025169","article-title":"Prolonged cardiac rhythm monitoring ad secondary stroke prevention in patients with cryptogenic cerebral ischemia","volume":"50","author":"Tsivgoulis","year":"2019","journal-title":"Stroke"},{"key":"2023080419242176200_euad212-B33","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/europace\/euac092","article-title":"Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA","volume":"24","author":"Skrebelyte-Str\u00f8m","year":"2022","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B34","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/europace\/euab036","article-title":"Smartphone electrocardiogram for detecting atrial fibrillation after a cerebral ischaemic event: a multicentre randomized controlled trial","volume":"23","author":"Koh","year":"2021","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B35","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/europace\/euab324","article-title":"Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke","volume":"24","author":"McIntyre","year":"2022","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejim.2021.05.038","article-title":"Device-detected atrial high rate episodes and the risk of stroke\/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis","volume":"92","author":"Vitolo","year":"2021","journal-title":"Eur J Intern Med"},{"key":"2023080419242176200_euad212-B37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/europace\/euaa139","article-title":"Mobile health applications for the detection of atrial fibrillation: a systematic review","volume":"23","author":"Lopez Perales","year":"2021","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/europace\/euab186","article-title":"Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices","volume":"24","author":"Miyazawa","year":"2022","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B39","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/eurheartj\/ehac020","article-title":"Silent brain infarcts impact on cognitive function in atrial fibrillation","volume":"43","author":"K\u00fchne","year":"2022","journal-title":"Eur Heart J"},{"key":"2023080419242176200_euad212-B40","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/europace\/euaa123","article-title":"Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V","volume":"22","author":"De With","year":"2020","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B41","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s11739-020-02551-5","article-title":"Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation","volume":"16","author":"Malavasi","year":"2021","journal-title":"Intern Emerg Med"},{"key":"2023080419242176200_euad212-B42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/euac062","article-title":"Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET\/EHRA consensus conference","volume":"25","author":"Schnabel","year":"2023","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B43","doi-asserted-by":"crossref","first-page":"ii46","DOI":"10.1093\/europace\/euaa424","article-title":"Early atrial fibrillation detection and the transition to comprehensive management","volume":"23","author":"Linz","year":"2021","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B44","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/europace\/euab078","article-title":"Size matters in atrial fibrillation: the underestimated importance of reduction of contiguous electrical mass underlying the effectiveness of catheter ablation","volume":"23","author":"Hartley","year":"2021","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B45","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med"},{"key":"2023080419242176200_euad212-B46","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/eurheartj\/eht031","article-title":"Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association","volume":"34","author":"Boriani","year":"2013","journal-title":"Eur Heart J"},{"key":"2023080419242176200_euad212-B47","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/europace\/euac118","article-title":"Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe","volume":"24","author":"Boriani","year":"2022","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B48","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/europace\/euac045","article-title":"Performance-based risk-sharing arrangements for devices and procedures in cardiac electrophysiology: an innovative perspective","volume":"24","author":"Boriani","year":"2022","journal-title":"Europace"},{"key":"2023080419242176200_euad212-B49","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/europace\/euac142","article-title":"Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey","volume":"24","author":"Boriani","year":"2022","journal-title":"Europace"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euad212\/50959024\/euad212.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/9\/euad212\/51040234\/euad212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/9\/euad212\/51040234\/euad212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T19:24:59Z","timestamp":1691177099000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euad212\/7229962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euad212","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,7,25]]},"article-number":"euad212"}}